Related references
Note: Only part of the references are listed.Hydroxyurea in children with sickle cell disease in a resource-poor setting: Monitoring and effects of therapy. A practical perspective
Uche Nnebe-Agumadu et al.
PEDIATRIC BLOOD & CANCER (2021)
Development of the InCharge Health Mobile App to Improve Adherence to Hydroxyurea in Patients With Sickle Cell Disease: User-Centered Design Approach
Nicole M. Alberts et al.
JMIR MHEALTH AND UHEALTH (2020)
Hydroxyurea Dose Escalation for Sickle Cell Anemia in Sub-Saharan Africa
Chandy C. John et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Robust clinical and laboratory response to hydroxyurea using pharmacokinetically guided dosing for young children with sickle cell anemia
Patrick T. McGann et al.
AMERICAN JOURNAL OF HEMATOLOGY (2019)
Greater number of perceived barriers to hydroxyurea associated with poorer health-related quality of life in youth with sickle cell disease
Arlene Smaldone et al.
PEDIATRIC BLOOD & CANCER (2019)
A Phase 3 Randomized Trial of Voxelotor in Sickle Cell Disease
Elliott Vichinsky et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Electronic Hydroxyurea Adherence: A Multidimensional Electronic Adherence Intervention That Improves Hydroxyurea Adherence in Children With Sickle Cell Disease
Susan Creary et al.
JMIR MHEALTH AND UHEALTH (2019)
Using Video Technology to Increase Treatment Completion for Patients With Latent Tuberculosis Infection on 3-Month Isoniazid and Rifapentine: An Implementation Study
Chee Kin Lam et al.
JOURNAL OF MEDICAL INTERNET RESEARCH (2018)
Patient-Centered eHealth Interventions for Children, Adolescents, and Adults With Sickle Cell Disease: Systematic Review
Sherif M. Badawy et al.
JOURNAL OF MEDICAL INTERNET RESEARCH (2018)
A Phase 3 Trial of L-Glutamine in Sickle Cell Disease
Yutaka Niihara et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Healthcare utilization and hydroxyurea adherence in youth with sickle cell disease
Sherif M. Badawy et al.
PEDIATRIC HEMATOLOGY AND ONCOLOGY (2018)
Gene Therapy in a Patient with Sickle Cell Disease
Jean-Antoine Ribeil et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Crizanlizumab for the Prevention of Pain Crises in Sickle Cell Disease
K. I. Ataga et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Effects of hydroxyurea treatment for patients with hemoglobin SC disease
Lori Luchtman-Jones et al.
AMERICAN JOURNAL OF HEMATOLOGY (2016)
Hydroxyurea Use in Young Children With Sickle Cell Anemia in New York State
David G. Anders et al.
AMERICAN JOURNAL OF PREVENTIVE MEDICINE (2016)
Technology Access and Smartphone App Preferences for Medication Adherence in Adolescents and Young Adults With Sickle Cell Disease
Sherif M. Badawy et al.
PEDIATRIC BLOOD & CANCER (2016)
Alpha-thalassaemia and response to hydroxyurea in sickle cell anaemia
Deepika S. Darbari et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2014)
Management of Sickle Cell Disease Summary of the 2014 Evidence-Based Report by Expert Panel Members
Barbara P. Yawn et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
A Pilot Study of Electronic Directly Observed Therapy to Improve Hydroxyurea Adherence in Pediatric Patients With Sickle-Cell Disease
Susan E. Creary et al.
PEDIATRIC BLOOD & CANCER (2014)
The effect of hydroxcarbamide therapy on survival of children with sickle cell disease
Clarisse Lopes de Castro Lobo et al.
BRITISH JOURNAL OF HAEMATOLOGY (2013)
Hydroxyurea adherence and associated outcomes among Medicaid enrollees with sickle cell disease
Sean D. Candrilli et al.
AMERICAN JOURNAL OF HEMATOLOGY (2011)
Drug therapy - Adherence to medication
L Osterberg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Concordant fetal hemoglobin response to hydroxyurea in siblings with sickle cell disease
MH Steinberg et al.
AMERICAN JOURNAL OF HEMATOLOGY (2003)
A two-year pilot trial of hydroxyurea in very young children with sickle-cell anemia
WC Wang et al.
JOURNAL OF PEDIATRICS (2001)
Share Paper
